Home
About
Technology
Pipeline
Investors
News
Contact

Home
About
Technology
Pipeline
Investors
News
Contact

Nouscom will present at Biocapital Europe

Home » Nouscom will present at Biocapital Europe

Nouscom will present at Biocapital Europe

Nouscom will present at Biocapital Europe2018-02-062018-05-14http://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.pngNouscomhttp://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.png200px200px

Find out the full program here: http://www.biocapitaleurope.com

Recent Posts

Nouscom will present at the NeoAg Summit 2018
Nouscom Strengthens Board of Directors with the Appointment of John F. McDonald as an Independent Director
Nouscom will present at the World Vaccine Congress Europe 2018
ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform

Contact

NOUSCOM
info@nouscom.com
nouscom.com

Our Privacy

Privacy Policy & Cookie Low

Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform, Exovax and Endovax, harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

Copyright All Rights Reserved © 2018 | Made with by

NousCom presents at Agenda Sachs ForumMeetings

Nouscom will present at the World Vaccine Congress Europe 2018Meetings

Utilizziamo i cookie per essere sicuri che tu possa avere la migliore esperienza sul nostro sito. Se continui ad utilizzare questo sito noi assumiamo che tu ne sia felice.Ok